Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Myles S. Is patient self-monitoring (including self-testing and selfmanagement) of oral anticoagulation therapy safe, efficacious and cost-effective? Glasgow: Quality Improvement Scotland (NHS QIS ). Evidence Note 27. 2009 Authors' conclusions Recent systematic reviews and meta analyses indicate that for selected and well trained patients, self-monitoring of oralanticoagulation therapy (OAT) is safe, more effective than usual care provided by family doctors and as effective as monitoring undertaken in specialised anticoagulation clinics and laboratories.These reviews should, however, be interpreted with caution. Differences in the trial settings, methods of patient self-monitoring and usual care comparators, alongside uncertainties regarding the nature and robustness of the quality assurance mechanisms underpinning the evidence may alter the magnitude of the effect estimates and their generalisability to UK care settings.Two recent economic models concluded that patient self-monitoring and testing of OAT was not cost effective compared toclinic-based usual care. Neither model was sufficiently transparent to enable the results to be generalised to the Scottish care setting. Scottish decision makers should therefore compare the annual costs of self-monitoring and training to the potential avoided costs from clinic-based usual care to judge cost effectiveness in their own settings.To operate any safe anticoagulation point of care test, robust quality assessment is essential. Timeliness warning This report has been archived and may contain outdated information. To request a copy of the report please contact the organisation directly. Indexing Status Subject indexing assigned by CRD MeSH Administration, Oral; Anticoagulantss; Point-of-Care Systems; Self Care Language Published English Country of organisation Scotland English summary An English language summary is available. Address for correspondence NHS Quality Improvement Scotland, Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6999; Fax: +44 141 221 3262 AccessionNumber 32011000039 Date abstract record published 26/01/2011 |